Summary. Co-agglutination (coagg) and latex agglutination (LA) tests were used for the detection of Salmonella serotype Typhi Vi and Barber protein (BP) antigens in sera from five groups of individuals (A-E). Group A consisted of 30 blood culture-positive cases of typhoid fever and group B consisted of 30 suspected cases of typhoid fever who had sterile blood cultures but positive Widal tests. Thirty cases of pyrexia of unknown origin (PUO) were placed in group C, while group D consisted of 15 cases of septicaemia caused by organisms other than Salmonella serotype Typhi. Group E comprised 50 normal healthy individuals with no history of typhoid fever or TAB vaccination in the previous 5 years. The Vi-LA test performed best with 96.7 YO of group A sera and 90 YO of group B sera giving positive results.
Introduction
The diagnosis of typhoid fever in endemic areas mainly depends on the isolation of Salmonella serotype Typhi from blood culture. This has certain disadvantages. Many cultures are falsely negative due to prior antibiotic therapy and results take at least 48-72 h. The currently available serological method for diagnosis of typhoid fever, the Widal test, requires both acute and convalescent sera and the results are often found to be unreliable in endemic area^.^^^ Therefore, for the purposes of rapid diagnosis it is preferable to detect Typhi antigen in the body fluids of patients with typhoid
The present study was undertaken to evaluate a co-agglutination (coagg) test and a latex agglutination (LA) test for the detection of soluble Typhi Barber protein antigen (BP)' and Vi antigen in patients' sera.
Materials and methods

Patients and controls
The typhoid fever group consisted of 60 patients with clinical and laboratory evidence of typhoid fever.
Received 22 Feb. 1994; revised version accepted 9 Feb. 1995.
The clinical diagnosis was based on the presence of unremitting fever for > 5 days and the presence of one or more of the following symptoms: systemic toxicity; fatigue ; abdominal symptoms ; transient rash ; anorexia; and a palpable spleen. Routine blood cultures and a Widal test with paired sera with a 1-week interval between collections were done in all 60 patients. A four-fold rise in titre of antibody to Typhi "0" and " H " antigens was considered as a positive Widal test result. Thirty blood culture-confirmed typhoid cases were assigned to group A and thirty blood culture-negative but Widal test-positive cases to group B. Group C consisted of 30 cases of pyrexia of unknown origin (PUO) which were bacteriologically sterile on blood culture and showed negative Widal tests with paired sera. The febrile control group (group D) comprised 15 bacteriologically confirmed cases of other non-typhoidal infectious diseases which also showed negative Widal tests. All these 15 cases were septicaemic and blood cultures yielded Escherichia coli, Klebsiella spp. (five each), Salmonella Paratyph A (three) and Salmonella Typhimurium (two). Group E consisted of 50 normal healthy individuals with no past history of typhoid fever or TAB vaccination in the previous 5 years. Blood ( 5 ml) was collected from all subjects and the serum was separated and stored at -20°C until tested. All agglutination tests were performed on sera collected within the first week after onset of fever.
Protein antigens
Typhi BP was prepared from Salmonella serotype Typhi strain 090 1 (National Phage Typing Centre, Lady Hardinge Medical College, New Delhi, India) by the method described by Barber et al. ' Briefly, harvested. washed and acetone-dried cells were extracted with veronal buffer (pH 8-4) and BP was purified by precipitation with trichloroacetic acid 10 %. The precipitate was washed, dissolved, dialysed against phosphate-buffered saline (PBS), pH 7.2, lyophilised and stored at 4°C until used. Protein antigens were also prepared from clinical isolates of Salmonella Paratyphi A, Salmonella Typhimurium, E. coli and Klebsielh pneumoniue by the same procedure. The protein content of these antigen preparations was determined by the method of Hartfee."
Preparation of rabbit antisera to BP
Antiserum to BP was raised in rabbits and subsequently purified." Adult albino rabbits (c. 2 kg in weight) were immunised in the two front foot pads and at four other subcutaneous sites with 1 mg of BP. One month later trial bleeding was done and antibody titres were measured by double immunodiffusion against Typhi BP. The animals with high antibody titres ( 2 2000) were bled and antisera were pooled. An equal volume of saturated ammonium sulphate (4°C) was added to pooled rabbit antisera to precipitate the globulin fraction and anti-BP immunoglobulin (IgG) was subsequently purified by DEAE ion-exchange chromatography.12 Standard Typhi Vi antigen and rabbit antiserum (titre 160) to Citrobacter ballerup Vi antigen was obtained from the Central Research Institute, Kasauli, India. Normal rabbit serum (NRS) was obtained from adult male rabbits.
Co-agglutination test
The co-agglutination test was performed by the method of Rockhill et al. ' Briefly, the Cowan I strain of Staphylococcus uureus (NCTC 8530) was first stabilised. In this method, harvested Staph. aureus cells were washed three times with PBS, suspended in formaldehyde 0.5 O h in PBS for 3 h, washed three times with PBS and then made up to a final suspension of 10 O/ * in PBS. The suspension was then heated at 80°C for 1 h with constant stirring, washed three times in PBS and stored as a stabilised suspension 10 YO in PBS at 4°C until coupled to the antiserum. One ml of this suspension was mixed with 0.2 ml each of C . ballerup Vi antiserum, anti-BP IgG and NRS. Each preparation was diluted 1 in 10 before use. The final diluted preparations were named as Vi-coagg, BP-coagg and NRS-coagg, respectively. Sera were tested with all three reagents simultaneously by mixing 50 pl of each reagent separately with 50 pl of serum and reading the results after 1-2 min. Tests showing agglutination of NRS-coagg reagent with serum were considered to be ~ninterpretable.~
Latex agglutination test
A 1 YO suspension of latex particles (diameter 0.778 pm; Sigma) was sensitised in 0-1 M glycine-0.15 M NaCl buffer (pH 8.2) with equal volumes of C . ballerup Vi antiserum, anti-BP IgG or NRS. 13 The latex suspensions and antisera were mixed continuously at room temperature for 2 h, after which bovine serum albumin (Sigma) 1 YO was added and the incubation was continued for 1 h. The latex particles were then washed (10000 g for 10 min) once in 0.1 M glycine -0.15 M NaCl, pH 8.2, buffer and finally suspended as a 1 % solution in the same buffer containing bovine serum albumin 1 % and sodium azide 0-02 YO. Latex reagents were denoted as Vi-LA, BP-LA and NRS-LA, respectively. Sera were tested by mixing 30 pl of serum with 10 pl of each latex reagent on a slide for 3-5 min on a mechanical rotator. The results were read visually. Tests showing agglutination of NRS-LA reagent with serum were considered to be uninterpretable.
Control agglutination tests
Protein antigens prepared as described from enteric bacteria other than Salmonella serotype Typhi were tested in 10-fold dilutions from 1 ng/ml to 1 mg/ml against all co-agglutination and latex reagents. 
Stat is t ical analysis
Results
The results of the co-agglutination and latex agglutination tests in the various patient groups are shown in table I. The latex agglutination test for detection of Vi antigen gave more positive results than any other test for group A patients (96.7%) while latex-based tests for the detection of Vi and BP antigens were both positive in 90% of group B patients. One of the five E. coli septicaemia cases (group D) gave a false positive reaction for Vi and BP antigens. There were no false positive reactions in group E. With the co-agglutination test, uninterpretable results were obtained with two sera in group For the purposes of statistical calculations, groups A and B were considered "true positive" and groups D and E as "true negative". The uninterpretable results were considered as negatives. Of all the tests (table 11) , latex agglutination for detection of Vi antigen showed the greatest sensitivity (93.3 YO), specificity (100 YO), positive predictive value (100 YO) and negative predictive value (94.2 YO). The minimum amount of Typhi BP antigen detected by both the coagglutination and latex agglutination tests was 10pglrnl. The Vi co-agglutination test and Vi latex agglutination tests could detect 1 pg/ml and 100 ng/ml of Typhi Vi antigen, respectively. Crossreactivity was observed only with Typhimurium protein antigen (1 mg/ml) which showed agglutination in both the BP co-agglutination and latex agglutination tests.
Discussion
Typhoid fever remains a major public health problem in developing countries and continues to be endemic in many areas. Detection of Typhi antigens in patients' body fluids4. 5 9 7 9 has advantages over blood culture and the Widal test, in that the results can be obtained more rapidly, there is no requirement for paired sera and the results are not affected by prior antibiotic therapy.
In the present study, the isolation rate of Salmonella serotype Typhi from blood cultures was low with only 30 (50%) of 60 patients with clinical and laboratory evidence of typhoid fever yielding positive cultures. This low isolation rate may be due to prior anti- A further feature of the present study was that the co-agglutination and latex agglutination tests could detect the presence of Vi and BP antigen in c. 30 YO and 20% of cases of PUO, respectively. These cases of PUO would have otherwise remained undiagnosed, although for confirmation of typhoid fever in such cases further evaluation of the specificity of these tests will be necessary.
Uninterpretable results obtained with the co-agglutination and latex agglutination tests accounted for In developing countries, where there is incomplete notification of infectious diseases and easy availability of antibiotics, patients with enteric fever often report to hospital either after self-medication or administration of antibiotics by private practitioners. In such cases, diagnosis by blood culture is often not confirmed, but detection of soluble antigen by Vi latex agglutination test would still be possible. The Vi latex agglutination test, being the most sensitive (93.3 YO) and specific (1 00 %), would be useful in primary health centres, as the test does not require a high degree of technical expertise, it is cheap to perform and the results are obtained within a few hours after collection of blood.
Although occasional non-specific reactions or uninterpretable results may limit its use, the Vi latex agglutination test is potentially suitable for the rapid detection of Typhi Vi antigen in patients' sera. However, these results should be further confirmed by conventional methods. In the present study, the number of patients with a proven diagnosis other than typhoid fever was relatively small and since there was one false positive among these 15 patients in several of the tests, it is important to extend this group and thus further validate the specificity of the Vi latex agglutination test.
